News | May 03, 2024
Bayer secures full ownership in Bayer Zydus Pharma by acquiring remaining 25% stake
The JV successfully leveraged the strengths of both companies to better serve the fast-growing Indian market
The JV successfully leveraged the strengths of both companies to better serve the fast-growing Indian market
Total value of the supplies of FC will be US$ 2.773 million
Fluid bed processes: drying, granulating, and coating in just one product container
Asahi Songwon Colors' shareholding in ALSPL has increased from 78% to 100%
The validations confirm the completion of the applications and commence the scientific review process
iSolveSM information on demand is the result of our focus on customer relationship
Exblifeb demonstrates remarkable efficacy in treating complicated Urinary Tract Infections (cUTI), pneumonia
Pivotal trial found the enfortumab vedotin plus pembrolizumab combination significantly extended overall and progression-free survival
GC1130A has previously achieved notable milestones by securing both RPDD and ODD from the U.S. FDA in January 2023
Comprehensive clinical development programs being initiated for each investigational candidate
Subscribe To Our Newsletter & Stay Updated
